In a move aimed at addressing growing concerns over brand name extensions in the pharmaceutical sector, the Drugs ...

The FDA recalled multiple lots of blood pressure medication Ziac by Glenmark due to possible cross-contamination ...

The Food and Drug Administration has recalled a popular treatment for high blood pressure. The agency said that bottles of ...

DCC suggests stakeholder consultation on use of same brand name for multiple drug formulations: Our Bureau, New Delhi Saturday, December 6, 2025, 08:00 Hrs [IST] The Drugs Consult ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

The Food and Drug Administration (FDA) classified the recall with a Class lll risk level, suggesting that exposure to the ...

Blood pressure medicine has been recalled because it may be cross-contaminated with another medication, according to reports.

Glenmark Pharmaceuticals Inc. in Elmwood Park, N.J., is recalling the pills, which are in 2.5 mg and 6.25 mg doses.

An update from Sihuan Pharmaceutical Holdings Group ( ($HK:0460) ) is now available. Sihuan Pharmaceutical Holdings Group Ltd. announced that its ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, researchers aren’t giving up yet.

Generic drugmakers continue to navigate a challenging U.S. market defined by persistent price erosion, intense competition ...

The Cleveland Clinic explains high doses can come with outsized risk—at times "fatal," they say—compared with other types of antihistamine.